top of page

February 28, 2024

Screenshot 2024-03-08 at

Skyhawk Therapeutics Progresses SKY-0515 Study in Huntington's Disease

Skyhawk Therapeutics, Inc. announces Phase 1 MAD initiation for SKY-0515 in Huntington's disease. Derived from their SKYSTAR® platform, SKY-0515 targets mutated huntingtin protein, offering potential benefits to patients lacking curative therapies. This marks a significant milestone in Skyhawk's quest for breakthrough treatments.

February 26, 2024

Screenshot 2024-02-29 at 1.58_edited.jpg

Laplace Interventional Announces Successful First in Human Procedure in Early Feasibility Study

Laplace Interventional, in collaboration with the Tucson Medical Center, achieved a medical breakthrough with the first-in-human implantation of its Transcatheter Tricuspid Valve Replacement (TTVR) system, targeting Tricuspid Regurgitation (TR). This minimally invasive procedure, conducted under FDA-approved study protocols, signals a promising advancement in cardiac care.

February 14, 2024

Screenshot 2024-02-14 at 4.59.35 PM.png

Neuro42 Receives FDA Clearance on Portable and Compact Brain MRI Scanner for Point of Care Imaging

Neuro42, a medical technology company, has obtained FDA clearance for its portable MRI scanner, eliminating the need for patient transport and improving diagnosis and treatment for neurological conditions. With a focus on accessibility and innovation, neuro42 aims to launch its MRI system in the US market this year, revolutionizing neuroimaging and surgical guidance.

February 2, 2024

Avation Medical.jpg

Avation Medical raises $22M+ from impressive line-up of new global investors

Avation Medical, an innovative neuromodulation and digital health company, announced more than $22 million in equity financing in its oversubscribed Series C round, led by new investors ShangBay Capital and Asahi Kasei, which included Angelini Ventures, JobsOhio Growth Capital Fund, and others.

Janurary 17, 2024


2023 SVB Health Care Report

Shangbay Capital has been ranked the most-active healthcare device investor by Silicon Valley Bank in their 2023 Healthcare Annual Report.

January 4, 2024


HSBC Venture Healthcare Report 2023

Shangbay Capital has been ranked the #2 most-active healthcare device investor by the 2023 HSBC Healthcare Annual Report.

bottom of page